Cardiovascular Risk according to the Components of Metabolic Syndrome in Type 2 Diabetes |
Lim, Dong-Mee
(Department of Internal Medicine, Konyang University Hospital)
Park, Keun-Young (Department of Internal Medicine, Konyang University Hospital) Kim, Byung-Joon (Department of Internal Medicine, Konyang University Hospital) Lee, Kang-Woo (Department of Internal Medicine, Konyang University Hospital) Lee, Myung-Jun (Department of Internal Medicine, Konyang University Hospital) Yom, Yoon-Shick (Department of Internal Medicine, Konyang University Hospital) Koh, Gwan-Pyo (Department of Internal Medicine, Jeju National Uninversity Hospiatal) |
1 | Wilson PW: Homocysteine and coronary heart disease how great is the hazard? JAMA 288:2042-3, 2002 DOI PUBMED ScienceOn |
2 | Kawamoto R, Tomita H, Oka Y, Ohtsuka N: Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Intern Med 45:605-14, 2006 DOI ScienceOn |
3 | Suk DJ, Rifai N, Buring JE, Ridker PM: Lipoprotein (a), measured with an assay independent of apolipoprotein (a) isoform size, and risk of future cardiovascular events among initially healthy women. JAMA 296:1363-70, 2006 DOI PUBMED ScienceOn |
4 | Reaven GM: Banting lecture 1998. Role of insulin resistance in human disease. Diabetes 37:1595-607, 1998 DOI PUBMED ScienceOn |
5 | Hajer GR, van der Graaf Y, Olijhoek JK, verhaar MC, Visseren FL: Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome. Heart 9:234-41, 2006 DOI ScienceOn |
6 | Helaine ER, Jeffrey H, Kristina J, Weiquan L, Giacomo R: Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians. Diabetes care 26:861-7, 2003 DOI ScienceOn |
7 | Gryndy SM, Brewer B, Cleeman JI, Smith SC, Lenfant C: Definition of metabolic syndrome: reportof the National Heart, Lung and Blood Institiue /American Heart Association conference on scientific issues related to definition. Circulation 109:433-8, 2004 DOI ScienceOn |
8 | Costa LA, Canani LH, Lisboa HRK, Tres GS, Gross JL: Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in type 2 diabetes. Diabet Med 21:252-5, 2004 DOI ScienceOn |
9 | Isomaa B, Henricsson M, Almgren P, Tuomi T, Taskinen MR, Groop: The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia 44:1148-54, 2001 DOI ScienceOn |
10 | Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486-97, 2001 DOI ScienceOn |
11 | Goya W, Gerald S, Lucy L, Richard WM: Metabolic syndrome vs Framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165:2644-50, 2005 DOI ScienceOn |
12 | Paul MR, Charles HM, Julie EB, Nader R: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. NEJM 342:836-43, 2000 DOI ScienceOn |
13 | Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-47, 1998 DOI PUBMED ScienceOn |
14 | Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-16, 2002 DOI ScienceOn |
15 | 이시훈, 강은석, 이광은, 김하동, 최성희, 김대중, 안철우, 차봉수, 임승길, 이현철, 허갑범: 대사증후군의 위험 예측인자로서 인슐린저항성. 대한내과학회지 63:54-60, 2002 |
16 | 임동미, 박근용, 고관표: 제2형 당뇨병환자에서 각 대사증후군의 정의(WHO, NCEP-ATP III, IDF)에 따른 심혈관질환의 예측능 비교. 대한당뇨병학회지 32:157-64, 2008 |
17 | Emdin M, Passino C, Pompella A, Paolicchi A: Gamma-glutamyl transferase as a cardiovascular risk factor. Eur Heart J 27:2145-6, 2006 DOI ScienceOn |
18 | Ioannidis G, Peppa M, Rontogianni P, Callifronas M, Papadimitriou C, Chrysanthopoulou G, Anthopoulos L, Kesse M, Thalassinos N: The concurrence of Microalbuminuria and Retinopathy with Cardiovascular Risk Factors; reliable predictors of Asymptomatic Coronary Artery Disease in Type 2 Diabetes. Hormones (Athens) 3:198-203, 2004 PUBMED |
19 | Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G: Fibrinogen as a risk factor for stroke and myocardial infarction. NEJM 311:501-5, 1984 DOI PUBMED ScienceOn |
20 | Dunder K, Lind L, Zethelius B, Berglund L, Lithell H: Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM). Am Heart J 148:596-601, 2004 DOI ScienceOn |
21 | Meerani P, Badimon JJ, Zias E, Fuster V, Moreno PR: Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications. Curr Mol Med 6:501-14, 2006 DOI ScienceOn |
22 | Bonora E, Targher G, Formenti G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Gemma L, Santi L, Bonadonna RC, Muggeo M: The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the verona diabetes complication study. Diabet Med 21:52-8, 2004 DOI ScienceOn |
23 | Isomass B, Almgren P, Tuomi T, Forsen B, Lahti K, Lissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683-9, 2001 DOI ScienceOn |